What question does urine organic acids analysis answer?
This test can matter after an abnormal newborn screen or when family history and symptoms point to an inherited metabolic disorder. Signs include acid buildup, low blood sugar, high ammonia, seizures, developmental changes, and unexplained illness. A commercial panel may give precise-looking answers that no one has proven. Acting on those claims can delay a check for more likely causes.
Clinical use
It looks for inherited metabolic signs
A biochemical-genetics laboratory compares groups of metabolites with the symptoms, age, family history, diet, medicines, and illness state. The result can point toward a named pathway that needs confirmation.
Timing
Results may be clearest during illness
Some disorders excrete more diagnostic metabolites during fasting, infection, vomiting, or another catabolic episode. A sample collected when symptoms are absent may be normal or nonspecific, so record whether an episode was underway.
Commercial panels
The same name can hide a different test question
Commercial wellness OAT panels may label markers as fungal, nutrient, neurotransmitter, oxalate, or mitochondrial findings. Those labels do not give the panel the diagnostic meaning of the dedicated clinical evaluation for each condition.
A clinical organic-acid result can support an inherited metabolic workup. It does not diagnose gut Candida or SIFO, measure brain dopamine, diagnose a B-vitamin deficiency, prove mitochondrial disease, or replace a dedicated 24-hour urine oxalate evaluation.
Save this test
Save the sample type, collection conditions, and result
A future clinician needs the full report and the collection context. Keeping the illness state, diet, medicines, supplements, creatinine, and follow-up beside the metabolites makes a repeat or second opinion much more useful.
This record keeps the urine result and illness details together. A specialist must diagnose inherited metabolic disease. Do not start fasting, protein restriction, antifungals, or supplements from this record.
How do age, sex, pregnancy, illness, and kidney function change the report?
Age, sex, pregnancy, illness state, diet, medicines, kidney function, muscle mass, and treatment can change the expected result or how urgently it needs follow-up. Read the report with the person's history, not against one adult wellness range.
Infants and children
Inherited metabolic disorders often first appear in childhood. Signs include poor feeding, vomiting, low blood sugar, acid buildup, high ammonia, seizures, developmental changes, unusual odor, or illness after fasting. Labs use age-based ranges. A child with severe sleepiness, breathing changes, seizures, or repeated vomiting needs urgent care.
Teenagers and adults
Some inherited disorders are mild, treated, or late-onset and may first become clear during infection, fasting, surgery, pregnancy, or another catabolic stress. A normal sample collected while well does not erase a convincing episode history.
Women, pregnancy, and postpartum
Pregnancy, labor, breastfeeding demands, vomiting, and postpartum recovery can change food intake and metabolic stress. Someone with a known inherited metabolic disorder needs a written plan from the metabolic and obstetric teams. Do not start fasting, protein restriction, or supplements from a commercial panel.
Men
Men need the same age, diet, medicine, family-history, illness, and kidney context. Sex can be part of the lab history. But the follow-up depends on the mix of metabolites and suspected pathway, not a generic male optimal range.
Older adults and kidney function
Kidney function, hydration, lower muscle mass, medicines, supplements, infection, and reduced food intake can affect urine concentration or creatinine-normalized results. Compare the report with serum creatinine, eGFR, medicine timing, and the clinical episode before labeling a mild marker as inherited disease.
What should you do before the urine collection?
Before the appointment, confirm which test is being ordered. A hospital or biochemical-genetics urine organic acid analysis for inherited metabolic disease is a different clinical question from a commercial wellness OAT panel.
Ask the laboratory whether it needs a random urine sample and whether the sample must be frozen immediately. Clinical laboratories commonly prefer a random sample that is not very dilute. Follow that laboratory's container, storage, and shipping instructions exactly.
Give the clinician and laboratory the person's age, sex, symptoms, family history, diet, medicines, and supplements. Include recent fasting, vomiting, fever, infection, hard exercise, surgery, or another acute illness because these can change the result.
Do not fast or trigger symptoms to make a disorder easier to find. If a metabolic specialist wants a sample during an illness, follow the written sick-day or emergency plan. Do not delay urgent care to collect urine.
Continue the usual medicines, protein, vitamins, and prescribed metabolic treatment before collection unless the ordering specialist gives a specific plan. Save the dose and timing so the interpreter can see the context.
Explain why the test was ordered
Share the symptoms, timing, family history, newborn-screening result, known diagnosis, and reason for testing. The laboratory needs to know whether it is investigating a possible inherited disorder, monitoring a known one, or reviewing an unexplained acute episode.
Collect and freeze the urine correctly
Many clinical laboratories use random urine and ask for immediate freezing. Use the supplied container. Unless the lab says otherwise, collect urine that isn't dilute. Record the collection time, illness state, food intake, medicines, and supplements.
Read the interpretive report
Gas chromatography-mass spectrometry (GC-MS) separates and measures many organic acids. The lab writes its interpretation from the full profile, age-based reference information, urine creatinine, and clinical history, not from one pass-or-fail score.
Confirm a meaningful result
Follow-up can pair the urine result with an acylcarnitine profile, ammonia, lactate, glucose, ketones, enzyme testing, or a gene test. The tests chosen should match the pathway named in the report.
How should you read urine organic acid results?
Start with the lab's final interpretation. Then check the measured compounds, units, creatinine adjustment, age-based ranges, sample handling, current illness, diet, medicines, supplements, and reason for testing. Do not treat each flag as a separate diagnosis.
No significant diagnostic finding
No significant diagnostic finding on the submitted sample, with adequate collection and relevant clinical history
The sample did not show a clear organic-acid profile for the laboratory to report. This lowers concern for disorders that reliably produce metabolites under those conditions, but it does not rule out intermittent, mild, treated, or well-compensated disease.
Nonspecific or collection-limited changes
Nonspecific, mild, isolated, treatment-related, diet-related, or collection-limited changes
Check urine concentration, creatinine, age, illness, fasting, diet, medicines, supplements, and sample handling. The clinician may plan a second urine sample when symptoms recur or choose a blood, enzyme, or genetic test for the suspected pathway.
A coherent result needing confirmation
A coherent group of metabolite changes that the biochemical-genetics laboratory identifies as concerning for a named pathway or disorder
This can support a metabolic diagnosis, but confirmation uses symptoms, examination findings, and tests chosen for the suspected condition. Urgent symptoms need metabolic or emergency care now, without waiting for confirmation.
A normal sample can be real and still miss an episodic disorder
Treatment, dilute urine, or collecting between illnesses can make the result less clear. If the illness history still fits, a specialist may repeat urine during an episode. They may add blood amino acids, acylcarnitines, enzyme studies, or genetic testing.
See research details
These checks separate the clinical metabolic-genetics report from claims about Candida, SIFO, neurotransmitters, nutrients, mitochondria, and oxalate.
Save every named metabolite, units, creatinine normalization, reference information, comments, and the final interpretation. Do not compare an isolated value from one laboratory with a different commercial panel as if the methods and questions were interchangeable.
A normal result does not rule out every disorder. If the history remains convincing, the metabolic team can match a planned repeat to the person's symptoms and add an acylcarnitine profile or another condition-specific test.
The emerging automated LC-MS/MS platform measured 25 organic acids, 8 amino acids, and 21 acylcarnitines in serum. It shows where laboratory methods may be heading, but it does not replace current clinical urine interpretation or prove commercial wellness-panel claims.
Even in that high-risk setting, renal function affected urine ratios and prospective performance was limited. A single commercial OAT value doesn't diagnose intestinal Candida or show a need for antifungal treatment.
The cited SIFO review describes the cutoff as arbitrary, imperfect, and not formally validated, and notes that colonization complicates interpretation. Neither a commercial urine organic-acid marker nor a breath test diagnoses SIFO.
Urine HVA reflects peripheral production and clearance. It cannot tell how much dopamine is available at a brain synapse or explain mood, attention, or motivation on its own.
Diet, medicines, fasting, age, low muscle mass, and other illness can create similar changes. Checking for mitochondrial disease uses the history and examination plus selected blood, urine, imaging, tissue, enzyme, or genetic studies, not one OAT value.
A value above 0.46 mmol/24 h can have diet, vitamin C, secondary hyperoxaluria, or primary hyperoxaluria context. A 2026 review estimated weighted endogenous oxalate production at 23.8 mg/day across 23 studies and 305 healthy participants, which reinforces that source and method matter.
What can you safely do while the result is being reviewed?
The safest useful work is to document the episode, follow the collection instructions, keep food and medicine context, and act quickly on warning signs. There is no safe home protocol for treating a suspected inherited metabolic disorder or a commercial OAT report.
Keep an episode record
Record sleep, infection, fever, vomiting, fasting duration, food intake, exercise, surgery, medicines, supplements, symptoms, and the urine collection time. This shows whether the reported changes appeared during catabolic stress or while well.
Avoid deliberate fasting or protein restriction
Do not fast, restrict protein, or stop a prescribed metabolic diet to provoke a result. Fasting and illness can trigger dangerous catabolism in some disorders. Follow the metabolic team's written sick-day plan if one exists.
Use targeted follow-up instead of a supplement pile
Do not start antifungals, high-dose vitamins, carnitine, binders, or a restrictive Candida diet from one commercial marker. Ask which named condition is suspected and which clinical test can confirm or reject it.
Treat acute metabolic warning signs as urgent
Poor feeding, repeated vomiting, dehydration, unusual sleepiness or lethargy, confusion, rapid or difficult breathing, seizure, collapse, or coma needs urgent medical assessment. Get care now, without waiting for a routine report or correcting the numbers at home.
Do not self-treat with antifungals, protein restriction, fasting, or supplements. A suspected inherited metabolic disorder belongs with a biochemical-genetics or metabolic specialist, and acute neurologic, breathing, feeding, or vomiting symptoms need urgent care.
What should you save in My Fog?
Keep these together
- Laboratory name, clinical or commercial purpose, collection date and time, random or timed urine, container, freezing, shipping, and whether the urine was dilute.
- Every reported metabolite, value, units, reference information, creatinine concentration or normalization, flags, comments, and the final interpretive report.
- Age, sex, pregnancy or postpartum context, kidney function, muscle mass concerns, family history, newborn-screening history, and known metabolic diagnosis.
- Illness, fever, vomiting, fasting duration, food intake, exercise, surgery, hydration, medicines, supplements, and prescribed metabolic treatment around collection.
- Save the exact symptoms and what you or your child couldn't do during an episode. Include changes in feeding, blood sugar, alertness, breathing, development, concentration, and recovery after illness.
- Metabolic-specialist interpretation, plasma amino acids, acylcarnitines, targeted nutrient or kidney tests, condition-specific confirmation, repeat conditions, and follow-up date.
Question for the visit
“Ask what clinical question this urine profile answers, whether the sample and timing were adequate, and what targeted test would confirm or reject the reported finding.”
Sources for Urine Organic Acids Analysis
Clinical indication, GC-MS method, random urine, report style, acute versus asymptomatic sampling, and interpretive limits.
Age and symptom context, acute metabolic presentations, and preference for random urine analysis when available.
Random frozen urine, dilution warning, age-aware interpretation, creatinine normalization, and required history.
Clinical metabolic indications, frozen random urine, and intermittent or minimal excretion limits.
Metabolic decompensation, fasting and illness risk, acute symptoms, sick-day care, and specialist treatment context.
Emerging serum LC-MS/MS platform, pediatric reference cohort, diagnosed IEM cohort, and measured analyte counts.
Current SIFO diagnostic limitations, small-bowel aspirate culture, commonly used 10³ CFU/mL cutoff, and colonization context.
D-arabinitol in invasive candidiasis, immunocompromised populations, renal effects, and validation limits.
Prospective urinary D-arabinitol monitoring performance in hematologic malignancy patients.
Clinical HVA use in neuroblastoma, catecholamine tumors, and rare metabolism disorders.
Monoamine metabolite testing, compartment limits, and why peripheral measures are not direct brain neurotransmitter readings.
Urine organic-acid sensitivity and specificity limits in mitochondrial disease and the wider diagnostic workup.
Current approach to suspected mitochondrial disease using multiple biochemical and genetic tests.
Dedicated stone and hyperoxaluria use, collection, adult interval, and diet or vitamin C context.
Systematic review of endogenous oxalate production, study count, participant count, and weighted estimate.
See each claim's sources
indication
Clinical urine organic acid analysis is used to investigate inborn errors of metabolism, including organic acidemias, fatty-acid oxidation disorders, and other inherited biochemical conditions.procedure
Clinical laboratories commonly analyze random frozen urine using gas chromatography-mass spectrometry and issue a qualitative interpretive report rather than a universal wellness score.preparation
Age, sex, diet, medicines, supplements, family history, symptoms, and whether collection occurred during an acute or asymptomatic period are needed for interpretation.limitation
A normal stable-state urine profile does not rule out every intermittent, mild, treated, or well-compensated inherited metabolic disorder.context
A 2026 study built pediatric intervals from 296 children and assessed 89 diagnosed patients using an emerging serum platform for 25 organic acids, 8 amino acids, and 21 acylcarnitines.limitation
D-arabinitol research concerns invasive candidiasis in immunocompromised or neutropenic patients and does not validate a commercial urine marker as a diagnosis of intestinal Candida or SIFO.interpretation
Current SIFO literature uses distal duodenal or jejunal aspirate culture, commonly at at least 10³ CFU/mL, while noting that the cutoff is arbitrary and not formally validated.limitation
Urine HVA has clinical uses in neuroblastoma and catecholamine-metabolism evaluation but does not measure brain dopamine, mood, or motivation.limitation
Urine organic acid abnormalities in mitochondrial disease can have low sensitivity during clinical stability and are rarely specific enough to diagnose mitochondrial disease alone.range
The dedicated Mayo 24-hour urine oxalate interval for age 16 and older is 0.11 to 0.46 mmol/24 h, and values above 0.46 mmol/24 h require diet, vitamin C, and hyperoxaluria context.context
A 2026 systematic review of 23 studies and 305 healthy participants estimated weighted endogenous oxalate production at 23.8 mg/day.safety
Fasting, illness, vomiting, and dehydration can trigger dangerous catabolism in some inherited metabolic disorders, so poor feeding, lethargy, confusion, breathing trouble, or seizure needs urgent assessment.